Related Experiment Videos

Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia

Jundong Huang1, Min Li1, Ji Li2

  • 1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.

Journal of the American Academy of Dermatology
|June 29, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Alopecia areataJAK inhibitorsPredictorsReal-world studyRelapseRitlecitinib

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...